David A Asch1,2, Natalie E Sheils3, Md Nazmul Islam3, Yong Chen4, Rachel M Werner1,2,5, John Buresh3, Jalpa A Doshi1,2. 1. Division of General Internal Medicine, University of Pennsylvania, Philadelphia. 2. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia. 3. UnitedHealth Group, Minnetonka, Minnesota. 4. Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia. 5. Cpl Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
Abstract
Importance: It is unknown how much the mortality of patients with coronavirus disease 2019 (COVID-19) depends on the hospital that cares for them, and whether COVID-19 hospital mortality rates are improving. Objective: To identify variation in COVID-19 mortality rates and how those rates have changed over the first months of the pandemic. Design, Setting, and Participants: This cohort study assessed 38 517 adults who were admitted with COVID-19 to 955 US hospitals from January 1, 2020, to June 30, 2020, and a subset of 27 801 adults (72.2%) who were admitted to 398 of these hospitals that treated at least 10 patients with COVID-19 during 2 periods (January 1 to April 30, 2020, and May 1 to June 30, 2020). Exposures: Hospital characteristics, including size, the number of intensive care unit beds, academic and profit status, hospital setting, and regional characteristics, including COVID-19 case burden. Main Outcomes and Measures: The primary outcome was the hospital's risk-standardized event rate (RSER) of 30-day in-hospital mortality or referral to hospice adjusted for patient-level characteristics, including demographic data, comorbidities, community or nursing facility admission source, and time since January 1, 2020. We examined whether hospital characteristics were associated with RSERs or their change over time. Results: The mean (SD) age among participants (18 888 men [49.0%]) was 70.2 (15.5) years. The mean (SD) hospital-level RSER for the 955 hospitals was 11.8% (2.5%). The mean RSER in the worst-performing quintile of hospitals was 15.65% compared with 9.06% in the best-performing quintile (absolute difference, 6.59 percentage points; 95% CI, 6.38%-6.80%; P < .001). Mean RSERs in all but 1 of the 398 hospitals improved; 376 (94%) improved by at least 25%. The overall mean (SD) RSER declined from 16.6% (4.0%) to 9.3% (2.1%). The absolute difference in rates of mortality or referral to hospice between the worst- and best-performing quintiles of hospitals decreased from 10.54 percentage points (95% CI, 10.03%-11.05%; P < .001) to 5.59 percentage points (95% CI, 5.33%-5.86%; P < .001). Higher county-level COVID-19 case rates were associated with worse RSERs, and case rate declines were associated with improvement in RSERs. Conclusions and Relevance: Over the first months of the pandemic, COVID-19 mortality rates in this cohort of US hospitals declined. Hospitals did better when the prevalence of COVID-19 in their surrounding communities was lower.
Importance: It is unknown how much the mortality of patients with coronavirus disease 2019 (COVID-19) depends on the hospital that cares for them, and whether COVID-19 hospital mortality rates are improving. Objective: To identify variation in COVID-19mortality rates and how those rates have changed over the first months of the pandemic. Design, Setting, and Participants: This cohort study assessed 38 517 adults who were admitted with COVID-19 to 955 US hospitals from January 1, 2020, to June 30, 2020, and a subset of 27 801 adults (72.2%) who were admitted to 398 of these hospitals that treated at least 10 patients with COVID-19 during 2 periods (January 1 to April 30, 2020, and May 1 to June 30, 2020). Exposures: Hospital characteristics, including size, the number of intensive care unit beds, academic and profit status, hospital setting, and regional characteristics, including COVID-19 case burden. Main Outcomes and Measures: The primary outcome was the hospital's risk-standardized event rate (RSER) of 30-day in-hospital mortality or referral to hospice adjusted for patient-level characteristics, including demographic data, comorbidities, community or nursing facility admission source, and time since January 1, 2020. We examined whether hospital characteristics were associated with RSERs or their change over time. Results: The mean (SD) age among participants (18 888 men [49.0%]) was 70.2 (15.5) years. The mean (SD) hospital-level RSER for the 955 hospitals was 11.8% (2.5%). The mean RSER in the worst-performing quintile of hospitals was 15.65% compared with 9.06% in the best-performing quintile (absolute difference, 6.59 percentage points; 95% CI, 6.38%-6.80%; P < .001). Mean RSERs in all but 1 of the 398 hospitals improved; 376 (94%) improved by at least 25%. The overall mean (SD) RSER declined from 16.6% (4.0%) to 9.3% (2.1%). The absolute difference in rates of mortality or referral to hospice between the worst- and best-performing quintiles of hospitals decreased from 10.54 percentage points (95% CI, 10.03%-11.05%; P < .001) to 5.59 percentage points (95% CI, 5.33%-5.86%; P < .001). Higher county-level COVID-19 case rates were associated with worse RSERs, and case rate declines were associated with improvement in RSERs. Conclusions and Relevance: Over the first months of the pandemic, COVID-19mortality rates in this cohort of US hospitals declined. Hospitals did better when the prevalence of COVID-19 in their surrounding communities was lower.
Authors: Chongliang Luo; Md Nazmul Islam; Natalie E Sheils; John Buresh; Martijn J Schuemie; Jalpa A Doshi; Rachel M Werner; David A Asch; Yong Chen Journal: J Am Med Inform Assoc Date: 2022-07-12 Impact factor: 7.942
Authors: Joy Tzung-Yu Wu; Miguel Ángel Armengol de la Hoz; Po-Chih Kuo; José Maria Castellano; Leo Anthony Celi; Joseph Alexander Paguio; Jasper Seth Yao; Edward Christopher Dee; Wesley Yeung; Jerry Jurado; Achintya Moulick; Carmelo Milazzo; Paloma Peinado; Paula Villares; Antonio Cubillo; José Felipe Varona; Hyung-Chul Lee; Alberto Estirado Journal: J Digit Imaging Date: 2022-07-05 Impact factor: 4.903
Authors: Austin S Kilaru; Kathleen Lee; Lindsay Grossman; Zachary Mankoff; Christopher K Snider; Eric Bressman; Stefanie B Porges; Keith C Hemmert; Scott R Greysen; David A Asch; Mucio K Delgado Journal: J Clin Med Date: 2021-05-03 Impact factor: 4.241
Authors: Michael A Puskarich; Nathan W Cummins; Nicholas E Ingraham; David A Wacker; Ronald A Reilkoff; Brian E Driver; Michelle H Biros; Fernanda Bellolio; Jeffrey G Chipman; Andrew C Nelson; Kenneth Beckman; Ryan Langlois; Tyler Bold; Matthew T Aliota; Timothy W Schacker; Helen T Voelker; Thomas A Murray; Joseph S Koopmeiners; Christopher J Tignanelli Journal: EClinicalMedicine Date: 2021-06-17
Authors: Simone A Jarrett; Kevin B Lo; Samir Shah; Martin Angelo Zanoria; Dahnish Valiani; Omotola O Balogun; Raul Hiedra; Zurab Azmaiparashvili; Gabriel Patarroyo Aponte Journal: Cureus Date: 2021-06-20